Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells. - Wikidata - wikimedia - TriplyDB

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

http://www.wikidata.org/entity/Q34987934

about

B cell regulation of the anti-tumor response and role in carcinogenesis Challenges for Preclinical Investigations of Human Biofield Modalities Immune cell promotion of metastasis Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses Novel immunotherapies for hematologic malignancies Unraveling the Anticancer Effect of Curcumin and Resveratrol Role of regulatory b cells in neuroimmunologic disorders Crosstalk of carcinoembryonic antigen and transforming growth factor-β via their receptors: comparing human and canine cancer Harnessing the Microbiome to Enhance Cancer Immunotherapy Characterization of c-Maf+Foxp3- Regulatory T Cells Induced by Repeated Stimulation of Antigen-Presenting B Cells.B cells and the humoral response in melanoma: The overlooked players of the tumor microenvironment B cells inhibit the antitumor immunity against an established murine fibrosarcoma Interleukin-35 induces regulatory B cells that suppress autoimmune disease.The roles of regulatory B cells in cancer B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas.Tumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective.Critical role for thymic CD19+CD5+CD1dhiIL-10+ regulatory B cells in immune homeostasis.Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.Generation and identification of tumor-evoked regulatory B cells Ex-vivo clonally expanded B lymphocytes infiltrating colorectal carcinoma are of mature immunophenotype and produce functional IgG.The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells.Immunoglobulin kappa C predicts overall survival in node-negative breast cancer.Enhanced frequency and potential mechanism of B regulatory cells in patients with lung cancer Layered signaling regulatory networks analysis of gene expression involved in malignant tumorigenesis of non-resolving ulcerative colitis via integration of cross-study microarray profiles.Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunity Characterization of antigen-specific B cells using nominal antigen-coated flow-beads.Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.Immunomodulatory antibody therapy of cancer: the closer, the better Distinctive immunoregulatory effects of adenosine on T cells of older humans.Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma.Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth Targeting the interleukin-6/Jak/stat pathway in human malignancies The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells Immunosuppressive and Prometastatic Functions of Myeloid-Derived Suppressive Cells Rely upon Education from Tumor-Associated B Cells.L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo.Characterization and Clinical Implication of Th1/Th2/Th17 Cytokines Produced from Three-Dimensionally Cultured Tumor Tissues Resected from Breast Cancer Patients.Immunity, inflammation, and cancer: an eternal fight between good and evil.A new paradigm for an old story: the role of regulatory B cells in cancer Immune microenvironment in tumor progression: characteristics and challenges for therapy

P2860

Q26738867-162DE118-5DDC-464A-BEC6-20D03A272044 Q26776019-6FDCC9A8-D177-4961-A2C6-8B51CDCE784F Q26991724-FEE3CD3E-F281-4AAA-B533-0EBE09DB4951 Q27001081-7025CC78-C52C-4720-90DF-190675A894E7 Q27004436-84F9E8D2-6BC9-466A-9D17-E37229BBDA68 Q28073155-5289CCEF-D10F-4091-B83F-90C5826DE5FE Q28077219-AC96B85A-A7A1-49A9-A502-E83E33E50B63 Q28084851-EA6168D2-7706-4B7E-9BAE-2824383DEA66 Q28088598-492E2BB3-ED90-4D80-B554-9E7DB606E6FC Q33556996-35F60FA2-86E9-49EE-B7E2-2077982F1D0D Q33632113-2E6F772C-C57F-4E9B-B99A-51EA348BCEA2 Q33684762-88597BEA-B57A-4069-BCA8-67C40970F4BF Q33721777-7A2F6938-9840-4E03-B9D4-661765B4215D Q33765986-DBA7A968-1D38-4070-946B-B7FEADBA83D5 Q33776937-A7843E70-C980-44EA-97BF-E8A33C6164C8 Q33795061-4FC4B1B7-B529-40CA-8C6B-AA34BCEAE630 Q33816764-5767BE2B-CFBB-4386-8B74-A2A35AA8FC02 Q34103969-A08819A2-EA44-4D64-95C4-382BA1C4E84E Q34138195-F0876048-C1E1-453F-B93B-114127250FD5 Q34185964-F6A3308E-8614-4B8D-BAEE-06F5967BAB07 Q34315871-08126966-F348-4133-B99A-ED9CAF38F048 Q34427347-E35AF857-D84A-45D9-8F70-CB7E89801151 Q34537331-59E40488-559E-4966-A90D-38A9F3C3F075 Q34794766-AFC706B6-8577-4B4A-B918-C8972A0C2489 Q35059053-1D31E7F5-F32E-4756-8948-C05D39187C8B Q35080887-CFB32B63-D426-46ED-99E1-B1C9F707E535 Q35110486-BE76DFBF-CE74-4FF8-AA05-63526133A4D4 Q35142851-8FB2D6AE-3FD0-4BD0-9AE3-53FCC45B84DE Q35787747-F9CAE77D-A4B0-4A84-B340-719F157A821A Q35797820-C006A4F1-686E-4C62-B9CB-97D60D729B4A Q35849866-2429A2D7-C770-4560-A0FB-9F64A782F809 Q35866355-912A8621-89BA-49B8-B3FC-0486C5355BBB Q35925127-A9F2A7A1-A0A2-41B0-AF4E-97D35814A37A Q35931795-33D4F243-6D15-4704-BDFC-1179D4733906 Q36021465-F348698C-6458-45E8-A87F-2E1CD90E65CF Q36035570-C503530F-969A-4419-98B9-7192991D54AB Q36038030-69DF0AB6-D6D3-46DC-89B6-DD1721CC3F4C Q36106053-FC6D23A6-93A9-47C2-BE56-19727953F65A Q36107944-2E8558E7-ACB1-43B5-A554-B53F4DFC3236 Q36178400-84A32D60-0411-48D5-8A1F-4A34F5DB041D

P2860

Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4⁺ T cells to T-regulatory cells.

http://www.wikidata.org/entity/Q34987934

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Tumor-evoked regulatory B cell ...... T cells to T-regulatory cells.

@ast

Tumor-evoked regulatory B cell ...... T cells to T-regulatory cells.

@en

Tumor-evoked regulatory B cell ...... T cells to T-regulatory cells.

@nl

type

label

Tumor-evoked regulatory B cell ...... T cells to T-regulatory cells.

@ast

Tumor-evoked regulatory B cell ...... T cells to T-regulatory cells.

@en

Tumor-evoked regulatory B cell ...... T cells to T-regulatory cells.

@nl

prefLabel

Tumor-evoked regulatory B cell ...... T cells to T-regulatory cells.

@ast

Tumor-evoked regulatory B cell ...... T cells to T-regulatory cells.

@en

Tumor-evoked regulatory B cell ...... T cells to T-regulatory cells.

@nl

P1433

Q34987934-A4F2C1E4-8199-4294-8731-F3C635D7751C

P1476

Q34987934-852984CE-FD82-42C0-9183-FADC37BDB13A

P2093

Q34987934-086B2722-4664-4ABB-9205-3BF3453F3C37

Q34987934-1E64306A-3BE8-410B-BFB1-B39AD6C46881

Q34987934-32E131E8-28BE-4D5F-B5EC-5DADF6271458

Q34987934-3D6C8E75-B858-49AE-9229-7E5E787492CC

Q34987934-3FB17850-ECF9-4E08-A74D-A76C405405F6

Q34987934-429A6AF1-23BE-420E-849A-F80D572FEE1C

Q34987934-7F3D9971-B864-4EF6-A1B9-5AB1A34F9E7C

Q34987934-83F077A9-1383-4F77-A20D-DEC9E34873AD

Q34987934-FD4D0609-A726-4980-9E8D-65D705BBBF31

P2860

Q34987934-15F234EE-01A6-4675-9168-4FFE26F84A12

Q34987934-165DC917-6A02-48A7-9F8A-85C73716F424

Q34987934-17CFFC15-45A9-44B0-9EB5-52C41E27DE20

Q34987934-181F70B4-2FB3-4180-81FF-731DAC79014F

Q34987934-1CACB5FB-B945-4CAC-AC94-AA7A62FFC859

Q34987934-23400BFB-114D-4659-878A-1932F98E81E3

Q34987934-23A062F7-6EC2-4EE4-B8FF-1E9C891FFEA1

Q34987934-23C87680-CC70-4C01-8030-53B0468239D3

Q34987934-25AEBFD4-A016-4C29-9DB8-F2572595698F

Q34987934-296BB71C-78EF-43F9-8080-2416CC14BE41

P304

Q34987934-E8BCCCB6-8403-4C0F-A578-6E5D42DBEE17

P31

Q34987934-B140FAB4-8160-4CFD-889B-9647A76BE893

P356

Q34987934-F486B833-3A56-4904-98BC-1007873E5E0E

P407

Q34987934-EF0E88F6-EDE7-4BAF-8A09-95EA2BD4D6EE

P433

Q34987934-0A25A247-51CA-48E9-99E0-44A48F8A895A

P478

Q34987934-EE40BF24-2863-48FD-8052-565E44A2820D

P577

Q34987934-1249496D-607D-4F52-A826-1449E43A1CF0

P5875

Q34987934-DAC8A57F-EFED-469E-82B2-6D602B492976

P698

Q34987934-5B199A3B-CF2C-42A7-8E3E-F8EFB9D1BBEC

P932

Q34987934-AAD214DD-36CF-4201-89BA-D71CBF213625

P356

0008-5472.CAN-10-4316

P1433

Cancer Research

P1476

Tumor-evoked regulatory B cell ...... T cells to T-regulatory cells.

@en

P2093

Arya Biragyn

http://www.w3.org/2001/XMLSchema#string

Bazarragchaa Damdinsuren

http://www.w3.org/2001/XMLSchema#string

Enkhzol Malchinkhuu

http://www.w3.org/2001/XMLSchema#string

Katarzyna Wejksza

http://www.w3.org/2001/XMLSchema#string

Monica Bodogai

http://www.w3.org/2001/XMLSchema#string

Purevdorj B Olkhanud

http://www.w3.org/2001/XMLSchema#string

Ranjan Sen

http://www.w3.org/2001/XMLSchema#string

Robert P Wersto

http://www.w3.org/2001/XMLSchema#string

Ronald E Gress

http://www.w3.org/2001/XMLSchema#string

P2860

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.

A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses.

P304

3505-3515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-4316

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50891755

http://www.w3.org/2001/XMLSchema#string

P698

21444674

http://www.w3.org/2001/XMLSchema#string

P932

3096701

http://www.w3.org/2001/XMLSchema#string